Welcome to our dedicated page for Owlet SEC filings (Ticker: OWLT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Owlet, Inc. (NYSE: OWLT) SEC filings page on Stock Titan provides direct access to the company’s regulatory disclosures, along with AI‑assisted summaries to help interpret complex documents. As a pediatric health platform offering FDA‑cleared medical and consumer pediatric wearables and connected cameras, Owlet’s filings give investors insight into how it manages growth, regulation, financing, and governance.
In Owlet’s Form 8‑K filings, readers can find information on quarterly financial results, equity offerings, warrant exchanges, executive leadership changes, corporate governance amendments, and settlements related to historical product matters. Recent 8‑Ks describe preliminary and final financial results, an underwriting agreement for a follow‑on equity offering, a warrant‑for‑share exchange approved by stockholders, and updates to the company’s certificate of incorporation and incentive award plan.
Definitive proxy statements (such as the DEF 14A) outline board structure, director elections, equity compensation plans, auditor ratification, and proposals requiring stockholder approval. These documents also discuss topics like officer exculpation provisions, stock issuance approvals, and the mechanics of Owlet’s annual meeting, giving a detailed view of the company’s governance framework.
On this page, you can monitor new 10‑K annual reports and 10‑Q quarterly reports as they are filed with EDGAR, along with any additional 8‑Ks and amendments. Stock Titan’s AI features summarize key sections, highlight risk factor themes, capital structure changes, and major contract disclosures, and surface notable items such as warrant exchanges or derivative litigation settlements. You can also review insider‑related information disclosed in connection with equity plans and exchanges, and track how Owlet describes regulatory, reimbursement, and market risks associated with its pediatric monitoring devices and digital health services.
Owlet, Inc. reported that Chief Financial Officer Amanda Crawford had 19,191 shares of common stock withheld on March 25, 2026 to cover tax obligations from vesting restricted stock units. These shares were not sold in the open market. After this tax-withholding disposition, she directly holds 131,134 shares of Owlet common stock.
Owlet, Inc. is registering the resale of up to 9,643,647 shares of Class A Common Stock. This shelf prospectus aggregates unsold shares previously registered under several prior S-1 filings and covers resale by certain registered holders, including shares issuable upon conversion of Series A and Series B preferred stock and shares issued in a warrant exchange.
The prospectus states the Company will not receive proceeds from these resales and that registered holders may sell shares publicly, privately, or through underwriters; the Company will bear registration expenses. The Common Stock trades on the NYSE under the symbol OWLT.
Owlet, Inc. reports strong 2025 progress as it shifts from a hardware-centric business to a broader pediatric health platform built around FDA‑cleared Dream Sock and prescription BabySat monitors, the Owlet360 subscription service, and its Dream Sight camera and Dream Duo system.
For 2025, Owlet generated $105.7 million in revenue, representing approximately 35.4% year‑over‑year growth, and achieved 50.6% gross margin. The company reported a net loss of $39.7 million but delivered about $2.0 million of positive Adjusted EBITDA, its first full year of positive Adjusted EBITDA, supported in part by a warrant exchange and follow‑on equity offering that strengthened its balance sheet.
Owlet, Inc. reported strong growth for 2025, with revenue rising to $105.7 million, up 35.4% from 2024, driven largely by higher sales of Dream Sock and Dream Duo products and growing subscription revenue. Full-year gross profit increased to $53.5 million and gross margin was 50.6%.
The company narrowed its operating loss to $8.3 million from $20.2 million and delivered adjusted EBITDA of $2.0 million, improving from a $1.8 million loss. GAAP net loss widened to $39.7 million, mainly due to a non-cash $26.6 million common stock warrant liability adjustment.
For 2026, Owlet expects revenue between $126 million and $130 million, implying high-teens to low-20s growth, gross margins of 49%–52% including tariff costs, and adjusted EBITDA of $3 million to $5 million. Management highlights more than 110,000 paying Owlet360 subscribers as an important recurring-revenue foundation.
Investment Company, Inc., an investment adviser based in Delaware, reports beneficial ownership of 1,748,251 Owlet Class A common shares, representing 6.3% of the class. The firm has sole voting and dispositive power over these shares through four affiliated investment funds and certifies the holdings are in the ordinary course of business, not intended to change or influence control of Owlet, Inc..
Owlet, Inc. filed an 8-K to note that the court hearing on a proposed settlement of shareholder derivative litigation has been continued to February 25, 2026. The settlement would resolve claims brought on Owlet’s behalf alleging fiduciary and disclosure breaches by former and current directors and officers.
Under the proposed deal, Owlet’s board agrees to adopt and maintain extensive governance and compliance reforms for at least eight years. These include a new board-level Audit and Risk Committee, a management-level Enterprise Risk Management Committee, and a management-level Disclosure Committee focused on accurate SEC and investor communications. The company will also enhance director education and cap outside board seats for independent directors and the chair.
Plaintiffs’ counsel will seek a court-approved fee and expense award of $675,000, from which $2,000 service awards would be paid to each plaintiff. There is no common cash fund for stockholders. Current holders as of April 2, 2025 may object or appear at the hearing by following the detailed procedures and deadlines described in the notice.
Owlet, Inc.'s Chief Financial Officer reports an automatic stock sale related to tax withholding. On January 20, 2026, CFO Amanda Crawford reported the sale of 183 shares of Owlet common stock at $13.33 per share. According to the filing, these shares were automatically sold in a non-discretionary transaction to cover taxes and fees tied to the vesting and settlement of restricted stock units. Following this small sale, Crawford beneficially owned 150,325 shares of Owlet common stock directly.
Owlet, Inc. President and CEO Jonathan Harris reported an automatic sale of 2,311 shares of common stock at $13.33 per share on January 20, 2026. The filing states that these shares were sold in a non-discretionary transaction to cover taxes and fees related to the vesting and settlement of restricted stock units. Following this tax-related sale, Harris beneficially owned 264,396 shares of Owlet common stock in direct ownership.
Owlet, Inc. has registered up to 5,346,194 shares of Class A common stock for resale by existing securityholders. These shares were issued to certain investors in exchange for previously outstanding Series A and Series B warrants under an Exchange Agreement dated August 7, 2025. Owlet will not receive any cash from the resale of these shares; any proceeds will go to the selling stockholders, who will also bear any underwriting discounts and selling commissions.
The exchanged shares are subject to a contractual lockup that generally prevents sales or transfers until April 8, 2026, limiting near-term resale activity. The prospectus also explains Owlet’s capital structure, including authorized common and preferred stock, the terms of its Series A and Series B convertible preferred shares, and governance and anti-takeover provisions that shape voting power, director elections, and potential change-of-control transactions.
Owlet, Inc. has filed a registration statement covering the resale of up to 5,346,194 shares of its Class A common stock by existing securityholders. These shares were issued in exchange for certain Series A and Series B warrants under an August 7, 2025 Exchange Agreement, simplifying the company’s capital structure by replacing warrants with stock.
The company will not receive any proceeds from sales of these shares; all sale proceeds will go to the selling stockholders, who will bear any underwriting discounts and selling commissions, while Owlet covers registration expenses. The registered shares are subject to a contractual lockup that generally restricts sales until April 8, 2026. Owlet’s common stock trades on the NYSE under the symbol “OWLT”, with a last reported price of $11.96 per share on November 20, 2025.